Clinical Trials

Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

Location:

Rochester,  MN

Trial status:

Open for Enrollment

Why is this study being done?

1. How does age at diagnosis affect prognosis in primary amyloidosis?

2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?

3. How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis?

4. How does initial treatment affect prognosis in primary amyloidosis?

4. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?

Who is eligible to participate?

Inclusion Criteria:

- Eligible for Stem cell transplantation less than age 75

Exclusion Criteria:

- Creatinine > 3.0

- BNP > 10000

Last updated: 02/27/2013

NCT ID: NCT01606280

IRB Number:11-005003